Development of methods to rapidly diagnose COVID-19 at high sensitivity without amplification
- Funded by RIKEN
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19start year
-99Known Financial Commitments (USD)
$0Funder
RIKENPrincipal Investigator
N/A
Research Location
JapanLead Research Institution
Molecular Physiology Laboratory, Chief Scientist LaboratoriesResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Diagnostics
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
Based on a "digital detection method of nucleic acids" developed by RIKEN, work is being carried out to rapidly develop a system to detect novel coronavirus-derived RNA rapidly and at high sensitivity, without the need for amplification